10.31.17
imec has joined ORCHID, a European initiative that will establish a European infrastructure to enable coordinated development, production and implementation of Organs-on-Chips by a consortium of academic and private partners. In total six European research institutions are involved.
Organs-on-Chips combine human mini-organs with microelectronics, microfluidics and nanosensors. This technology is already providing new platforms for drug discovery but is poised to deliver applications in personalized medicine and safety pharmacology, and offers alternatives to conventional animal testing. Over the next two years, the EU will invest €500,000 in the ORgan-on-CHip In Development (ORCHID) project.
The ORCHID platform will provide overviews and updates of current and new Organ-on-Chip initiatives so that users can track progress easily, consult developers directly and identify gaps in present knowledge, limiting implementation.
Organs-on-Chips combine human mini-organs with microelectronics, microfluidics and nanosensors. This technology is already providing new platforms for drug discovery but is poised to deliver applications in personalized medicine and safety pharmacology, and offers alternatives to conventional animal testing. Over the next two years, the EU will invest €500,000 in the ORgan-on-CHip In Development (ORCHID) project.
The ORCHID platform will provide overviews and updates of current and new Organ-on-Chip initiatives so that users can track progress easily, consult developers directly and identify gaps in present knowledge, limiting implementation.
